Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: The TALENT study

Journal of Hypertension

Volumn 29, Issue 3, 2011, Pages 600-609

  Mancia, Giuseppe ^a   Parati, Gianfranco ^a,b   Bilo, Grzegorz ^a,b   Choi, Jasmine ^c,d   Kilama, Michael Ochan ^c,d   Ruilope, Luis M ^e  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c Bayer Schering Pharma   (United States)

^d Bayer Schering Pharma   (Italy)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

angiotensin receptor antagonists; blood pressure; calcium antagonists; combination treatment; diabetes; hypertension; metabolic syndrome

Indexed keywords

NIFEDIPINE; TELMISARTAN;

ADULT; AGED; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; ERECTILE DYSFUNCTION; FEMALE; FLUSHING; HUMAN; HYPERTENSION; HYPOTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOTHERAPY; MORNING DOSAGE; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 79951672624     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328342ef04     Document Type: Article

References (33)

1. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
3. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL; Other experts who contributed to parts of the guidelines:, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:375-2414.
4. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351:1755-1762. (Pubitemid 28269185)
5. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11000 participants from 42 trials. Am J Med 2009; 122:290-300.
6. Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004; 363:2049-2051. (Pubitemid 38781107)
7. Mourad JJ, Waeber B, Zannad F, Laville M, Duru G, Andréjak M, investigators of the STRATHE trial. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/ indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens 2004; 22:2379-2386. (Pubitemid 39620288)
8. Corrao G, Parodi A, Zambon A, Heiman F, Filippi A, Cricelli C, et al. Reduced discontinuation of antihypertensive treatment by two drug combination as 1st step. Evidence from daily life practice. J Hypertens 2010; 28:1584-1590.
9. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27:963-975.
10. Battershill AJ, Scott LJ. Telmisartan. A review of its use in the management of hypertension. Drugs 2006; 66:51-83. (Pubitemid 43148989)
11. Croom KF, Wellington K. Modified-release nifedipine. A review of the use of modified-release formulations in the treatment of hypertension and angina pectoris. Drugs 2006; 66:497-528.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
13. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G.The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16:1685-1691. (Pubitemid 28515496)
14. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527-1535. (Pubitemid 37410190)
15. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-1315. (Pubitemid 33016494)
16. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111:1777-1783. (Pubitemid 40525142)
17. Staessen JA, ThijsL, Fagard R,O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546. (Pubitemid 29380290)
18. Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Pattern of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypertens 2000; 18:1691-1699.
19. Düsing R. Adverse events, compliance, and changes in therapy. Curr Hypertens Rep 2001; 3:488-492.
20. Nicotra F, Wettermark B, Sturkenboom MC, Parodi A, Bellocco R, Ekbom A, et al. Management of antihypertensive drugs in three European countries. J Hypertens 2009; 27:1917-1922.
21. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ 1999; 160:41-46. (Pubitemid 29054225)
22. Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 2005; 19:607-613. (Pubitemid 41131661)
23. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G. Reproducibility of noninvasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens 1991; 9:115-119.
24. Conway J, Johnston J, Coats A, Somers V, Sleight P. The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens 1988; 6:111-116. (Pubitemid 18095831)
25. De la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens 2009; 23:503-511.
26. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-h blood pressure variability. J Hypertens 1993; 11:1133-1137. (Pubitemid 23307888)
27. Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000; 102:1536-1541.
28. ManciaG, Bombelli M,Facchetti R,Madotto F,Corrao G, Trevano FQ, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007; 49:1265-1270. (Pubitemid 46809367)
29. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
30. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Press 1995; 4:148-156.
31. Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Hennig M, Zanchetti A. Assessment of long-term antihypertensive treatment by clinic an ambulatory blood pressure. Data from the ELSA Study. J Hypertens 2007; 25:1087-1094; (la ref. indicata a mano si riferisce al paper 'metabolico' di ELSA).
32. Mancia G, Omboni S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001; 19:1755-1763. (Pubitemid 32924940)
33. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004; 22:435-445. (Pubitemid 38368472)